Investigational Site Number : 1240009

Toronto, Ontario M5T 3A9

1 studies enrolling now · 3 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Hidradenitis Suppurativa

Studies at this site

• Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa — Recruiting now
• A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD — Running, not enrolling
• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed